Newell Brands Reports Q4 & FY2025 Results, Issues Cautious 2026 Outlook with Significant Impairment

summarizeSummary

Newell Brands reported a significant GAAP net loss for Q4 and FY2025 due to a $340 million impairment charge, alongside continued sales declines, while providing a cautious 2026 outlook with flat to slightly lower normalized EPS but strong cash flow generation.

check_boxKey Events

• Significant Impairment Charge Drives GAAP Net Loss

  The company reported a GAAP net loss of $315 million for Q4 2025 and $285 million for FY2025, primarily due to a $340 million non-cash impairment charge related to indefinite-lived tradenames.

• Continued Sales Decline

  Net sales for Q4 2025 decreased by 2.7% to $1.9 billion, with full-year 2025 net sales down 5.0% to $7.2 billion, reflecting ongoing core sales declines.

• Mixed Normalized Performance

  Q4 2025 normalized operating margin improved to 8.7% from 7.1% year-over-year, and normalized diluted EPS increased to $0.18 from $0.16. However, full-year 2025 normalized EPS declined to $0.57 from $0.68.

• Cautious 2026 Outlook

  Newell Brands initiated full-year 2026 guidance for net sales of (1%) to 1% and normalized EPS of $0.54 to $0.60, which includes an incremental $0.07 tariff headwind, indicating a flat to slightly lower EPS compared to 2025.

auto_awesomeAnalysis

Newell Brands' latest earnings report reveals a challenging financial landscape marked by a substantial non-cash impairment charge of $340 million, which significantly impacted GAAP profitability for both the fourth quarter and full year 2025. The company continues to grapple with declining sales, although normalized operational metrics showed some improvement in Q4. The 2026 outlook suggests a stabilization in sales trends but offers a flat to slightly lower normalized EPS compared to 2025, even with an expected increase in advertising and distribution. A key positive is the strong projected operating cash flow for 2026, which could help with liquidity and debt management. Investors will likely focus on the persistent sales weakness, the material impairment, and the lack of significant EPS growth in the near-term outlook, despite the operational efficiency efforts.